For how we live.
The government is gathering evidence to build step-count and muscle-strengthening guidance into the Physical Activity Guidelines for Americans, a supplement to the 2018 edition. Written comments close 12 November 2026.
In a 12-month trial of 89 older adults with vascular cognitive impairment, strength training did not slow whole-brain white-matter lesions overall — but it did in women, and in two specific brain regions.
A short walk after eating blunts the post-meal blood-sugar spike. Trials in people with type 2 diabetes and in healthy adults agree, and light walking beats standing, which beats sitting still.
The popular 21-day rule has no basis in the habit-formation research. In the one real-world study, the time to reach automatic behaviour ranged from 18 to 254 days — and plateaued on average near 66.
You cannot burn fat off a specific area by exercising it. When researchers trained a single limb or drilled abdominal muscles for weeks, fat came off the body generally, not the spot being worked.
Standing up every half hour is common desk advice. A meta-analysis of seven trials found brief standing breaks trim post-meal glucose a little, but short light-walking breaks cut both glucose and insulin far more.
You cannot turn a healthy immune system up like a dial, and nothing on the supplement shelf has been shown to. What the trials do show is narrower: fix a sleep deficit and you catch fewer colds.
Percussive devices reliably loosen muscles and add short-term flexibility, but pooled trials show no clear gain for maximal-strength recovery or next-day soreness — and they can dent explosive output before training.
Exercising before breakfast shifts which fuel your body uses during the session, but pooled trials find no meaningful edge for weight or body-fat loss over the same workout done fed.
Walking pads promise movement without leaving your desk. A trial found walking while working slowed typing but did not harm cognition; a second found hourly walking cut post-meal glucose and blood pressure.
For most women without complications, activity in pregnancy is safe and beneficial. Trials link exercise to lower odds of gestational diabetes and high blood pressure, with a rough dose to aim for.
Losing the ability to walk is a turning point in later life. In a large randomised trial, structured activity cut the rate of major mobility disability — evidence that movement protects independence, read honestly.
Even frail people in their 80s and 90s roughly doubled their strength in ten weeks of training. But muscle size barely moved — the honest expectation is a big gain in function and a modest one on the scale.
The global target is an average of 60 minutes a day of moderate-to-vigorous activity, plus muscle-strengthening. Most adolescents miss it: in 2016, 81% worldwide were insufficiently active, and girls more than boys.
Observational studies disagree — evening looked best in adults with obesity, morning-to-midday in the wider population. None is a trial, and total activity dwarfs timing.
A large treadmill cohort found the least-fit adults had about five times the death rate of the fittest — a bigger risk than coronary disease, smoking or diabetes. But it measures a state, not a lever.
A harmonised meta-analysis of over a million adults found high sitting time raised mortality — but about 60 to 75 minutes a day of activity erased that risk. Being inactive, not the chair itself, did most of the damage.
In 2,292 older adults, weak quadriceps tracked with higher mortality — but muscle size, measured by CT and DXA, did not. The finding reshaped how sarcopenia is defined and moved the target from bulk to strength.
The old RICE drill was never built on strong trial evidence, and newer guidance drops the ice and anti-inflammatories. The durable parts are protection, gentle loading and time.
A pooled study of 1.44 million adults links activity to lower risk of 13 cancers — but not all, and not melanoma. A 2025 randomised trial now shows exercise after colon cancer improves survival.
The endorphin story is a long-standing guess. When researchers blocked opioid signalling in 63 runners, the euphoria and calm still arrived — pointing to the body's own cannabis-like molecules instead.
A study of 3,932 athletes found cyclists had no worse erectile or urinary function than swimmers and runners. But heavy saddle time is tied to genital numbness, and men logging 5+ hours a week showed lower sperm counts.
A harmonised meta-analysis of over a million adults found 60 to 75 minutes of daily moderate activity erased the extra death risk tied to sitting more than eight hours. The catch is how much activity that is.
A 17-cohort meta-analysis links each extra 1,000 daily steps to 15% lower mortality, and brisk walkers outlive slow ones. But walking builds little strength or top-end fitness.
Two Cochrane reviews found that for ordinary acute low back pain, advice to rest in bed is slightly worse than advice to stay active. For sciatica, it makes little difference either way.
An umbrella review of 41 systematic reviews found sitting, standing and 'bad' posture are at most weakly and inconsistently linked to low back pain — and none of it establishes that posture is the cause.
In 25,241 non-exercisers, three brief daily bursts of vigorous activity tracked with markedly lower mortality. A small trial found stair-climbing 'snacks' raised fitness. The catch: they must be genuinely vigorous.
A meta-analysis of 11 trials put the change in a healthy man's resting testosterone from training at zero. Endurance work can lower it; losing body fat is the lever that reliably raises it.
The idea that a little stress makes the body stronger is sound biology, and the best-evidenced example is ordinary exercise. Stretched to cold, fasting and antioxidant pills, the human evidence thins fast.
Pooled trials show foam rolling briefly improves flexibility and eases muscle soreness, but its effects on strength, power and recovery are small to negligible — and the injury and 'fascia' claims are unsupported.
In the LIFTMOR trial, brief twice-weekly heavy lifting raised spine bone density in postmenopausal women with low bone mass, while a gentle home programme lost ground. A Cochrane review finds a smaller but real effect.
Guidelines and trial evidence point to a target, not a tally: work each muscle group about twice a week and match recovery to effort. Training something every day is not, by itself, harmful.
In 34,485 older adults, each 0.1 m/s of walking speed tracked with better survival. At age 75, predicted 10-year survival ran from 19% to 91% across the range — but speed reflects health, not the reverse.
No pill in the anti-ageing market has mortality data like physical activity. The largest cohorts show most of the benefit arrives at half the recommended dose, and more brings diminishing returns.
Frailty has firm diagnostic criteria and predicts falls, hospital stays and death. It is also, unusually, treatable: resistance training raised muscle strength 113% even in nursing-home residents in their late 80s.
In 216 patients with chronic patellofemoral pain across 10 Korean hospitals, an 8-week digital therapeutic beat education and exercise instruction on pain — by 12.5 mm on a 100 mm scale.
The association was strongest where the air was worst — which is the tell. A parallel US survey finds the indoor facilities are the ones vanishing from low-income neighbourhoods.
Leisure exercise reliably protects the heart. Physical activity done for a living shows mixed or even adverse associations — and some meta-analyses find higher mortality in men with the most physically demanding jobs.
A large trial in adults up to 89 found structured activity cut the risk of losing the ability to walk. In frail nursing-home residents near 90, strength training more than doubled muscle strength.
Head-to-head against an ECG chest strap, popular optical wrist devices differed substantially, and one graded test found a smartwatch running a couple of beats low with a 28-bpm spread in its limits of agreement.
The same sport that a 300,000-person Swedish cohort associated with a 40% lower death rate carries an injury incidence in professionals roughly six times that of amateurs. The difference is dose.
Across 89,573 accelerometer-monitored adults and 678 conditions, no disease showed a significant difference between activity concentrated in one or two days and activity spread through the week.
A Cochrane review found sit-stand desks reliably reduce workplace sitting, but graded the evidence low quality and could not tie it to better health. WHO backs cutting sedentary time but set no number.
In a free-living comparison, three devices counted steps within about 18% of a research monitor but one overestimated active-calorie burn by 139%. A lab study found step counts collapse when walking is slow.
A harmonised meta-analysis of more than a million people found the association between sitting time and death disappeared in the most active quarter. In the least active, it did not disappear at all.
Observational studies tie fitness to slower cognitive decline. When researchers randomise older adults to exercise, the cognitive payoff shrinks — in a Cochrane review of healthy people, to nothing.
A dose-response meta-analysis of 94 cohorts and more than 30 million people found the steepest part of the curve sits between zero and the recommended weekly dose, with small and uncertain gains above double it.
An umbrella review of 41 systematic reviews found no consensus that posture causes back pain. And correcting posture reliably changes alignment — but not, consistently, pain.
A 2025 meta-analysis of 57 studies found the mortality curve bending at about 7,000 steps a day. The 10,000 figure traces to the trade name of a Japanese step counter sold in 1965.
Two 2026 meta-analyses put a number on it: roughly a thousand extra steps daily in older adults and in heart patients. The catch is duration — the gains faded once the intervention stopped.
Three cohorts, 147,374 people, 30 years and 35,798 deaths. The dose-response curve flattened above 120 minutes per week, and the cancer signal appeared at the low end, not the high end.
Using genetic variants as instruments, researchers found exercise and wellbeing lowered risk of PCOS, endometriosis and menstrual disorders, while screen time and mood swings raised it.
Pooled across dozens of trials, activity trackers add roughly 1,800 steps a day and about 1 kg of weight loss. Effects on blood pressure, cholesterol and blood sugar are small and often not significant.
A UK Biobank analysis finds high step counts do not offset short sleep. A US cohort finds one-minute bursts matter. And in older adults, most step-count differences vanish after adjusting for age and sex.
A review found wearables gave valid maximal-oxygen-uptake estimates in most studies of untrained and recreational exercisers. A separate meta-analysis pooled a 0.83 correlation, with high variability.
A December survey found getting stronger is the leading 2026 health goal. The best meta-analysis of muscle-strengthening and mortality finds a benefit that plateaus at around 30 to 60 minutes a week.
Nearly a million conscripts followed for three decades: obesity carried a 3.1-fold hazard for sepsis, and high cardiorespiratory fitness was associated with a 42% lower risk of dying from bacterial infection.
Half a million Ontario users held a small average gain over 24 months. The least active gained nearly 2,000 steps a day — and the most active lost almost 4,000.
Twenty untrained women cycled at four fixed workloads wearing four popular low-cost bands, checked against indirect calorimetry. Every device drifted further from the truth as effort rose.
A Spanish trial in 4,746 adults compared an energy-reduced Mediterranean diet plus exercise against the same diet eaten freely. Over six years the absolute gap was 12.0% versus 9.5%.
A meta-analysis of pedometer, tracker and smartwatch interventions lasting 12 to 48 weeks found no significant change in systolic or diastolic pressure — nor in weight, glucose or HbA1c.